Neutral impactCorporate Action

Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth

BusinessLine 1 hr ago·4 Nov 2026, 12:08 pm

The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue

Affected stocks

Neutral1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Ennature BIO Pharma (ENNATURE).
  • Category: Corporate Action.

Why it matters

A routine update for Ennature BIO Pharma. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at BusinessLine.

More Stocks news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.